Brian Axe

Brian Axe, Managing Director at NovaQuest Capital Management, has over 20 years of experience in the biomedical industry across pharmaceuticals, animal health, and medical devices. He is a member of the investment committee of NovaQuest Animal Health Opportunities Fund. He is responsible for leading the Firm’s animal health strategy through portfolio management, sourcing, negotiating, due diligence, structuring of investment opportunities, and post-close investment management.

Mr. Axe joined NovaQuest in 2017 after 15 years at Eli Lilly and Co. and Elanco Animal Health, where he began in Lilly Research Labs as an Analytical Chemist and held various leadership positions including Due Diligence Advisor for Elanco Business Development. As Due Diligence Advisor, he led corporate and scientific & technical due diligence teams and advised therapeutic area leadership as well as business development on transaction opportunities.

Mr. Axe earned his degree in Biochemistry from Bowling Green State University and is a certified Alliance Management Professional.